Issue 1 | September 2014
  [a watchful eye]

Dear Colleagues:

I’m pleased to introduce you to Compliant Views – Innovative Consultants GXP’s new e-newsletter, sharing our expert perspective on the evolving regulatory landscape and resources and tools to assist with your continued compliance goals.

It takes vigilance for companies to comply with complex FDA regulations and international regulatory standards. Using IcGXP’s resources and decades of experience in the pharmaceutical, medical device, combination product and biotech industries, we can help you keep close watch on compliance trends and emerging issues in enforcement to avoid damaging business interruptions and thrive in today’s competitive global marketplace.

Each month, Compliant Views will take a look at best practices in quality system development, provide guidance on getting audit-ready and share our unique point of view on news and trends with the potential to impact your products, services and operations.

 

Join the Conversation

Please join me on my next Webinar on September 23rd – Current Good Manufacturing Practices (cGMPs) – offered in conjunction with Compliance Online, the largest GRC Advisory Network. I will cover how to comply with the FDA’s cGMPs regulations and avoid costly pitfalls. Click here for more information and to register.

And in the coming weeks, we will be unveiling IcGXP’s new website, including an interactive Ask the Experts feature. We look forward to your feedback.

At IcGXP we help clients mitigate risk, improve quality and achieve profitability. Learn what we can deliver as your resource partner.

Connect

[about IcGXP]

Compliant Views is authored by Phil Russ, owner and principal consultant at IcGXP, a premier regulatory compliance firm with a unique risk-based approach to compliance and quality operations, serving many of the world’s leading pharmaceutical and medical device manufacturers. IcGXP provides expert compliance auditing, risk management and quality system development services meeting the compliance needs of firms from product development through commercialization. The IcGXP team includes senior subject matter experts experienced with all regulatory compliance requirements related to the pharmaceutical, medical device, combination product and biotech industries along with a staff of seasoned technical professionals to supplement firm’s changing resource needs.